Search results

The purpose of this paper is to explore the characteristics of small-scale cannabis cultivation in New Zealand and Israel.

An online survey of predominantly small-scale cannabis cultivators had previously been conducted in 11 countries in 2012/2013. The same core online survey was subsequently conducted in New Zealand and Israel in 2016/2017, and comparisons made with the original 11 countries.

Only around one third of the New Zealand and Israeli cannabis growers had sold cannabis, and the majority of these did so only to cover the costs of cultivation. The median number of cannabis plants cultivated per crop by the New Zealand and Israeli growers was five and two, respectively. The leading reasons provided for growing cannabis by both the New Zealand and Israeli growers were to provide cannabis for personal use and to share with others. A higher proportion of New Zealand than Israeli growers reported growing cannabis for medicinal reasons. A total of 16 per cent of the New Zealand and 17 per cent of Israeli growers had come into contact with the police due to their cannabis cultivation. The findings suggest small-scale cannabis cultivation in New Zealand and Israel is largely a means of “social supply” of cannabis, and this is consistent with the findings from the original 11 countries. The higher incidence of growing cannabis for medicinal purposes in New Zealand may reflect the limited official access to medical cannabis. Significant minorities of small-scale cannabis growers in both countries had contact with police, putting them at risk of the negative consequences of a criminal conviction.

To date, the research into cannabis cultivation has largely consisted of studies of individual countries. However, given the global popularity of cannabis use, and the recent spread of cannabis cultivation to countries that traditionally have not produced cannabis, via utilisation of indoor growing techniques, there is now a strong case for international comparative research. Following the success of the surveys in the original 11 countries, New Zealand and Israeli members of the Global Cannabis Cultivation Research Consortium international collaboration chose to undertake surveys in their own countries in 2016/2017.

It is conceivable that cannabis cultivators who grow for medical purposes aim to improve the therapeutic index of their cannabis by attempting to produce particular concentrations of CBD and/or THC. The purpose of this paper is to examine whether small-scale medical cannabis growers differ from those growing for recreational reasons in terms of self-assessed concentrations of THC and CBD in the cannabis they grow.

Data collection was conducted online from a convenience sample of 268 cannabis growers visiting a popular Israeli cannabis internet forum. χ² and Kruskal–Wallis H were used to test bivariate associations between medical and recreational cannabis cultivators in terms of self-assessed cannabinoid concentrations.

In total, 40 percent of cannabis growers reported that they grow for medical purposes. Medical cannabis growers were more likely to report that they thought they knew the cannabinoid concentrations of the cannabis they grew and they reported higher self-assessed concentrations of THC, but not CBD.

Compared to recreational growers, medical cannabis growers are more likely to strive to be informed in terms of the content of their cannabis. Medical growers may also be attempting to grow more potent THC but not CBD cannabis.

Possessing a strong ethnic identity and ethnic network are described in some epidemiological literature as moderating factors in the relation between perceived discrimination and varying types of substance use in people with a migration background (PMB). The purpose of this paper is to qualitatively explore problem use, discrimination, ethnic identity and social networks in a small purposive sample of users with a Turkish and Eastern European migration background in Ghent, Belgium.

The authors present data retrieved within the framework of a qualitative community-based participatory research study that primarily aims to understand the nature of substance use in PMB. In the secondary analysis, the authors focus on a sub-study examining substance use by people with a Turkish (n=55) and Eastern European (n=62) migration background and explore how individuals perceive discrimination, ethnic identity and (ethnic) social networks in 117 qualitative interviews.

Almost all the respondents in this study reported perceived (inter-)ethnic discrimination. The authors establish that problem users in this study have a complex but albeit weak sense of ethnic identity nor do they have a strong ethnic network. This, in combination with perceived discrimination, is a risk factor for continued problem substance use and may hamper recovery related to problem use.

This article intends to lay the groundwork for future research that should focus more on longitudinally studying the intertwined relation between problem use, discrimination, ethnic identity and especially social instead of solely ethnic networks, their complex nature as well as their relation to recovery processes among persons with a migration background.

Objective. The objective of this study was to examine practices and policies in place for the provision of targeted prevention and treatment of cocaine and Amphetamine Type Stimulant (ATS) users in prison in nine European countries. Methodology. Across nine European member states (Belgium, the Netherlands, Czech Republic, Lithuania, Slovenia, Sweden, Malta, Ireland and Portugal), interviews were conducted with ministerial representatives and professionals (i.e. service providers and security officials) working in prisons and a total of 16 focus groups with a total of 125 prisoners. Results. The use of stimulants in prison is associated with aggression and violence, financial problems, and psychological and physical problems in prisoners (depression, anxiety and psychological craving). Both security and healthcare staff in prison often feel ill‐equipped to deal with stimulant‐related problems, leading to a lack of equivalence of care for stimulant users in prison, therefore the variety and quality of drug services outside is not reflected sufficiently inside prison. There is a need for more specific product information and harm reduction material on stimulants, for clear guidelines for the management of acute stimulant intoxication and stimulant withdrawal, for structural adjustments to improve potential diagnosis of personality and psychiatric disorders, for more non‐pharmacological treatment strategies and more opportunities for prisoners to engage in purposeful activities.

Unlike other plant‐based drugs, cannabis is increasingly grown within the country of consumption, requires minimal processing before consumption, and can be easily grown almost anywhere using indoor or outdoor cultivation techniques. Developments in agronomic technologies have led to global growth in domestic cultivation, both by cannabis users for self‐ and social‐supply, and by more commercially‐oriented growers. Cross‐national research is needed to better understand who is involved in domestic cultivation, the diversity in cultivation practices and motivations, and cultivators' interaction with the criminal justice system and cannabis control policies.

The article introduces the Global Cannabis Cultivation Research Consortium (GCCRC), describes its evolution and aims, and outlines the methodology of its ongoing cross‐national online survey of cannabis cultivation.

Despite differing national contexts, the GCCRC successfully developed a core questionnaire to be used in different countries. It accommodates varying research interests through the addition of optional survey sections. The benefits to forming an international consortium to conduct web‐based survey research include the sharing of expertise, recruitment efforts and problem‐solving.

The article discusses the limitations of using non‐representative online sampling and the strategies used to increase validity.

The GCCRC is conducting the largest cross‐national study of domestic cannabis cultivation to date. The aim is not only to better understand patterns of cannabis cultivation and how they differ between countries but also to build upon online engagement methodology with hidden populations.

The purpose of this paper is to document a leading UK cannabis activist’s efforts to bring about policy change and to convey his human story as a medical consumer. The paper contends that it is not enough to present evidence-based policies to effect change in drug policy, it is also vital to tell human stories, which people can relate to, in order to develop narratives which speak to people’s values.

An in depth, unstructured interview was conducted between Dr Melissa Bone and Cannabis Activist, Greg de Hoedt in December 2017. The interview was recorded, transcribed and formed the basis of the paper, which was co-edited and co-created by both authors.

The paper charts Greg’s journey from being a cannabis consumer – to being diagnosed with Crohn’s – to being a cannabis activist. The paper interweaves a drug policy discussion with a personal narrative. It connects unique insights into Greg’s life with the broader forces and institutions which influence cannabis policy at a local, national and international level.

Incorporating Greg’s personal narrative within an academic platform integrates his experiential knowledge into the “expert” evidence base. Alongside the potential of personal narratives to facilitate the production of knowledge, Greg’s emotive story could help to shape the public’s perception of cannabis, which could subsequently influence policy.

This study aims to understand how different levels of streamer channels influence luxury brand sales in live streaming commerce. This study also seeks to understand the conditions under which luxury brands may benefit more from different level streamer channels.

Panel data were collected from 17 international luxury brands on the Douyin live streaming platform in an 18 week period from August to December 2020 and analyzed by using a two-way fixed effects model.

The authors compared different mega-, macro- and micro-streamer channels within live streaming commerce and found that the densities of mega- and macro-streamer channels had significant positive impacts on luxury brand sales in live streaming commerce. Moreover, the effects of the density of streamer channel on luxury brand sales were moderated by such variables as product line breadth, product line depth, product type (star/non-star) and product price (high/low). The authors found that product line breadth and depth could reduce the positive impact of the densities of mega- and macro-streamer channels on luxury brand sales. For star products and high-priced products, the relationship between the density of mega-streamer channel and luxury brand sales was more likely to be observed than for non-star products and low-priced products. The relationship between the density of macro-streamer channel and luxury brand sales was more likely to be observed in low-priced products than in high-priced products.

The findings make important contributions to the literature in that the authors expand the influencer-brand fit theory by proposing a new model of effects of the densities of mega-, macro- and micro-streamer channels on sales performance across different luxury products to improve our understanding of the fit among influencers, brands and products. This helps luxury brands make basic decisions of “who sells” and “sells what” when engaging in live streaming commerce.